1220 / 1345
6
What do we know about dose to
pathological nodes?
Pittsburgh, IJROBP 2015:
0% after boost dose of 55Gy
EMBRACE I:
12% failures within nodes
boosted to a median dose
of 59Gy
Ramlov et al, Acta Oncol, 2015:
limited dose effect for
pathological nodes (~55-
65Gy boosts)
Nodal recurrence in pathological nodes after
boost